Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

239
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
239
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

263
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
263
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

222
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
222
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

257
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
257
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

712
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
712

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

From Migration to Emergency: A Systematic Review of Acute Presentations Following Late Esophageal Stent Migration.

Journal of clinical medicine·2026
Same author

Ocular metastasis from esophageal cancer: a systematic review and pooled analysis of individual-level case data.

Surgery today·2026
Same author

Sigmoid Colon Perforation into an Infected Pelvic Lymphocele after Pelvic Lymphadenectomy and Radiotherapy for Recurrent Endometrial Cancer: a Rare Diagnostic and Therapeutic Challenge.

Maedica·2026
Same author

Pattern of lymph node spread in gastric cancer: Western multicenter retrospective study.

BJS open·2026
Same author

Management of iatrogenic esophageal perforations: a systematic review of non-surgical causes.

Surgical endoscopy·2026
Same author

Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies.

Life (Basel, Switzerland)·2026

相关实验视频

Updated: Feb 8, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

2.0K

老年患者的阿哈拉西亚:一个全面的概述

Evgenia Mela1, Orestis Lyros2, Vasileios Charalampakis3

  • 1First Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece. vemela@hotmail.gr.

Digestive diseases and sciences
|February 7, 2026
PubMed
概括

阿哈拉西亚是一种食道运动障碍,在老年人中越来越多地被诊断出来. 高龄不是有效治疗的障碍,需要特定于年龄的治疗策略.

关键词:
亚喀拉西亚亚喀拉西亚是指亚喀拉西亚的一个地区.年长的老人.消化道的 消化道老年人医院 老年人医院运动障碍 运动障碍

更多相关视频

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia
09:46

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

1.4K
Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

3.6K

相关实验视频

Last Updated: Feb 8, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

2.0K
Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia
09:46

Author Spotlight: Cutting-Edge Robotic Heller Myotomy Protocol for Treatment of Achalasia

Published on: February 16, 2024

1.4K
Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

3.6K

科学领域:

  • 胃肠病学 胃肠病学
  • 老年医学 老年医学
  • 食道运动障碍 食道运动障碍

背景情况:

  • 阿哈拉西亚是一种罕见的食道运动障碍,影响食道下部关节的放松和周围静止.
  • 由于全球人口老龄化,老年人患病率正在增加.

研究的目的:

  • 审查老年患者中阿卡拉西亚的临床表现,诊断和管理.
  • 突出与年龄相关的阿喀拉西亚表现和结果的差异.

主要方法:

  • 文献搜索侧重于与年龄相关的症状,诊断和治疗结果的差异.
  • 分析当前关于老年人阿喀拉西亚管理的证据.

主要成果:

  • 老年患者往往表现出不那么明显的症状,营养不良/渴望的风险更高,以及晚期的疾病.
  • 高分辨率计量是诊断的黄金标准,前面是内镜.
  • 治疗方案包括肉毒毒素,肺部扩张和手术肌肉切除.

结论:

  • 晚年不应该排除终极的阿喀拉西亚治疗,特别是微创的选择.
  • 制定基于证据的,年龄特定的建议对于优化老年阿喀拉西亚患者的治疗结果至关重要.